Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

Clinical trial NCT05438251 · TERMINATED

Trial details

NCT number: NCT05438251
Sponsor: Oneness Biotech Co., Ltd.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Foot Ulcer (DFU)

Start date: 2022-08-04
Primary completion: 2024-04-03
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.